Panos Kefalas

Panos Kefalas is the Head of Health Economics and Market Access at Cell and Gene Therapy Catapult (London, UK).

Kefalas has more than 18 years of experience in pharmaceutical pricing, reimbursement and health economics, gained from senior roles within major health economics and outcomes research, and market access consultancy firms, including ICON plc and United BioSource Corporation (both London, UK).

Kefalas has also managed guideline development at the National Institute for Health and Care Excellence (London, UK).